logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 6
  • 1
    Kerr, David James
    Born in June 1956
    Individual (6 offsprings)
    Officer
    2022-12-22 ~ now
    OF - Director → CIF 0
  • 2
    La Thangue, Nicholas Barrie, Prof
    Born in November 1957
    Individual (8 offsprings)
    Officer
    2022-05-24 ~ now
    OF - Director → CIF 0
  • 3
    Banaag, Arnold James
    Born in September 1967
    Individual (1 offspring)
    Officer
    2025-01-21 ~ now
    OF - Director → CIF 0
  • 4
    Reddy, Sandip Bobby
    Born in November 1971
    Individual (1 offspring)
    Officer
    2024-04-19 ~ now
    OF - Director → CIF 0
  • 5
    Sender, Leonard Stanley
    Born in August 1958
    Individual (3 offsprings)
    Officer
    2024-04-19 ~ now
    OF - Director → CIF 0
  • 6
    Patrick Soon-shiong
    Born in July 1952
    Individual (3 offsprings)
    Person with significant control
    2024-04-19 ~ now
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
Ceased 7
  • 1
    Prof Nicholas Barrie La Thangue
    Born in November 1957
    Individual (8 offsprings)
    Person with significant control
    2022-05-24 ~ 2022-12-22
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
  • 2
    Noble, James Julian
    Director born in March 1959
    Individual (1 offspring)
    Officer
    2022-12-22 ~ 2024-04-19
    OF - Director → CIF 0
  • 3
    Fleming, William John Robert
    Cfo born in October 1966
    Individual (2 offsprings)
    Officer
    2022-05-24 ~ 2024-09-18
    OF - Director → CIF 0
  • 4
    Kerry, Simon, Dr
    Company Director born in July 1963
    Individual (6 offsprings)
    Officer
    2022-12-22 ~ 2024-04-19
    OF - Director → CIF 0
  • 5
    Dixon-clegg, Nicholas George
    Investor born in November 1989
    Individual (8 offsprings)
    Officer
    2022-12-22 ~ 2024-04-19
    OF - Director → CIF 0
  • 6
    Soon-shiong, Patrick
    Company Director born in July 1952
    Individual (3 offsprings)
    Officer
    2024-04-19 ~ 2024-12-15
    OF - Director → CIF 0
  • 7
    Taylor, Richard Kirby
    Financier born in October 1959
    Individual
    Officer
    2022-12-22 ~ 2023-08-17
    OF - Director → CIF 0
parent relation
Company in focus

INGENOX THERAPEUTICS LIMITED

Previous name
CELLERON THERAPEUTICS HOLDINGS LIMITED - 2023-01-26
Standard Industrial Classification
64209 - Activities Of Other Holding Companies N.e.c.
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
1,547,583 GBP2024-12-31
0 GBP2023-06-30
Property, Plant & Equipment
25,634 GBP2024-12-31
0 GBP2023-06-30
Fixed Assets - Investments
7,128 GBP2024-12-31
2,565,356 GBP2023-06-30
Fixed Assets
1,580,345 GBP2024-12-31
2,565,356 GBP2023-06-30
Debtors
585,189 GBP2024-12-31
842,732 GBP2023-06-30
Cash at bank and in hand
1,040,043 GBP2024-12-31
524,400 GBP2023-06-30
Current Assets
1,625,232 GBP2024-12-31
1,367,132 GBP2023-06-30
Creditors
Current, Amounts falling due within one year
-850,283 GBP2024-12-31
-190,203 GBP2023-06-30
Net Current Assets/Liabilities
774,949 GBP2024-12-31
1,176,929 GBP2023-06-30
Total Assets Less Current Liabilities
2,355,294 GBP2024-12-31
3,742,285 GBP2023-06-30
Creditors
Non-current, Amounts falling due after one year
-7,562,089 GBP2024-12-31
Net Assets/Liabilities
-5,206,795 GBP2024-12-31
2,655,982 GBP2023-06-30
Equity
Called up share capital
3,223 GBP2024-12-31
2,825 GBP2023-06-30
Share premium
1,321,520 GBP2024-12-31
1,025,446 GBP2023-06-30
Other miscellaneous reserve
490,000 GBP2024-12-31
1,639,128 GBP2023-06-30
Retained earnings (accumulated losses)
-7,021,538 GBP2024-12-31
-11,417 GBP2023-06-30
Equity
-5,206,795 GBP2024-12-31
2,655,982 GBP2023-06-30
Average Number of Employees
02023-07-01 ~ 2024-12-31
02022-07-01 ~ 2023-06-30
Intangible Assets - Gross Cost
Goodwill
1,444,101 GBP2024-12-31
0 GBP2023-06-30
Intangible Assets - Gross Cost
1,547,583 GBP2024-12-31
0 GBP2023-06-30
Intangible Assets - Accumulated Amortisation & Impairment
Goodwill
0 GBP2023-06-30
Intangible Assets - Accumulated Amortisation & Impairment
0 GBP2023-06-30
Intangible Assets
Goodwill
1,444,101 GBP2024-12-31
0 GBP2023-06-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
25,208 GBP2024-12-31
0 GBP2023-06-30
Computers
426 GBP2024-12-31
0 GBP2023-06-30
Property, Plant & Equipment - Gross Cost
25,634 GBP2024-12-31
0 GBP2023-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
0 GBP2023-06-30
Computers
0 GBP2023-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
0 GBP2023-06-30
Property, Plant & Equipment
Plant and equipment
25,208 GBP2024-12-31
0 GBP2023-06-30
Computers
426 GBP2024-12-31
0 GBP2023-06-30
Investments in group undertakings and participating interests
7,128 GBP2024-12-31
2,565,356 GBP2023-06-30
Amount of corporation tax that is recoverable
Current
537,723 GBP2024-12-31
0 GBP2023-06-30
Amounts Owed By Related Parties
0 GBP2024-12-31
Current
830,501 GBP2023-06-30
Other Debtors
Amounts falling due within one year
47,466 GBP2024-12-31
12,231 GBP2023-06-30
Debtors
Current, Amounts falling due within one year
585,189 GBP2024-12-31
842,732 GBP2023-06-30
Trade Creditors/Trade Payables
Current
264,711 GBP2024-12-31
115,653 GBP2023-06-30
Amounts owed to group undertakings
Current
308,410 GBP2024-12-31
0 GBP2023-06-30
Other Creditors
Current
8,746 GBP2024-12-31
0 GBP2023-06-30
Accrued Liabilities/Deferred Income
Current
268,416 GBP2024-12-31
74,550 GBP2023-06-30
Creditors
Current
850,283 GBP2024-12-31
190,203 GBP2023-06-30
Par Value of Share
Class 1 ordinary share
0 GBP2023-07-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
3,222,889 shares2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
692,984 GBP2024-12-31
Related profiles found in government register
  • INGENOX THERAPEUTICS LIMITED
    Info
    CELLERON THERAPEUTICS HOLDINGS LIMITED - 2023-01-26
    Registered number 14127227
    Magdalen Centre Robert Robinson Avenue, Oxford Science Park, Oxford OX4 4GA
    PRIVATE LIMITED COMPANY incorporated on 2022-05-24 (3 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2025-05-23
    CIF 0
  • INGENOX THERAPEUTICS LIMITED
    S
    Registered number 14127227
    Magdalen Centre Robert Robinson Avenue, Oxford Science Park, Oxford, United Kingdom, OX4 4GA
    Limited By Shares in Companies House, England And Wales
    CIF 1 CIF 2
child relation
Offspring entities and appointments
Active 2
  • 1
    Magdalen Centre Robert Robinson Avenue, Oxford Science Park, Oxford, United Kingdom
    Active Corporate (2 parents)
    Equity (Company account)
    161,900 GBP2024-12-31
    Person with significant control
    2022-12-22 ~ now
    CIF 2 - Right to appoint or remove directors → OE
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
  • 2
    Magdalen Centre Robert Robinson Avenue, Oxford Science Park, Oxford, England
    Active Corporate (2 parents)
    Equity (Company account)
    464,037 GBP2024-12-31
    Person with significant control
    2022-12-22 ~ now
    CIF 1 - Right to appoint or remove directors → OE
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.